Cargando…

Interleukin-6: a new therapeutic target in systemic sclerosis?

Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells, except lymphocytes and hepatocytes, express the functio...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Reilly, Steven, Cant, Rachel, Ciechomska, Marzena, van Laar, Jacob M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232056/
https://www.ncbi.nlm.nih.gov/pubmed/25505952
http://dx.doi.org/10.1038/cti.2013.2